The therapeutic and diagnostic potential of amyloid β oligomers (AβOs) selective antibodies to treat Alzheimer’s disease is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R41AG054337-01
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
National Institutes of Health
Grant: 1RF1AG063903-01
Defining native proteoform landscape for amyloid-beta in Alzheimers disease
National Institutes of Health
Grant: 1R21AG045637-01A1
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
Fields of Study
Keywords
Sustainable Development Goals